http://akampioneer.com Thu, 02 Feb 2012 19:00:15 +0000 en hourly 1 http://wordpress.org/?v=3.1.1 http://akampioneer.com/company-news/company-news-medigene-presents-overall-survival-data-from-a-phase-ii-trial-of-endotag%c2%ae-1-in-triple-negative-breast-cancer-tnbc.html http://akampioneer.com/company-news/company-news-medigene-presents-overall-survival-data-from-a-phase-ii-trial-of-endotag%c2%ae-1-in-triple-negative-breast-cancer-tnbc.html#comments Fri, 09 Dec 2011 09:00:58 +0000 akampion http://akampioneer.com/?p=1836 http://akampioneer.com/company-news/company-news-medigene-presents-overall-survival-data-from-a-phase-ii-trial-of-endotag%c2%ae-1-in-triple-negative-breast-cancer-tnbc.html/feed 0 http://akampioneer.com/company-news/company-news-medigene-sells-full-european-rights-for-eligard%c2%ae-to-astellas-for-eur-25-million-and-ongoing-royalties.html http://akampioneer.com/company-news/company-news-medigene-sells-full-european-rights-for-eligard%c2%ae-to-astellas-for-eur-25-million-and-ongoing-royalties.html#comments Tue, 20 Jul 2010 13:16:44 +0000 akampion http://akampioneer.com/?p=455 http://akampioneer.com/company-news/company-news-medigene-sells-full-european-rights-for-eligard%c2%ae-to-astellas-for-eur-25-million-and-ongoing-royalties.html/feed 0 http://akampioneer.com/company-news/company-news-medigene-expands-commercialization-of-veregen-to-china-and-south-korea.html http://akampioneer.com/company-news/company-news-medigene-expands-commercialization-of-veregen-to-china-and-south-korea.html#comments Mon, 10 May 2010 08:18:24 +0000 akampion http://akampioneer.com/?p=327 http://akampioneer.com/company-news/company-news-medigene-expands-commercialization-of-veregen-to-china-and-south-korea.html/feed 0 http://akampioneer.com/company-news/company-news-medigene-publishes-first-preliminary-results-from-a-phase-ii-clinical-trial-of-endotag-1-for-the-treatment-of-triple-receptor-negative-breast-cancer.html http://akampioneer.com/company-news/company-news-medigene-publishes-first-preliminary-results-from-a-phase-ii-clinical-trial-of-endotag-1-for-the-treatment-of-triple-receptor-negative-breast-cancer.html#comments Thu, 06 May 2010 16:01:46 +0000 akampion http://akampioneer.com/?p=314 http://akampioneer.com/company-news/company-news-medigene-publishes-first-preliminary-results-from-a-phase-ii-clinical-trial-of-endotag-1-for-the-treatment-of-triple-receptor-negative-breast-cancer.html/feed 0 http://akampioneer.com/company-news/company-news-medigene-signs-commercialization-agreement-for-veregen-probiogen-is-granted-new-divisional-patent-on-duck-cell-line.html http://akampioneer.com/company-news/company-news-medigene-signs-commercialization-agreement-for-veregen-probiogen-is-granted-new-divisional-patent-on-duck-cell-line.html#comments Thu, 01 Apr 2010 08:27:41 +0000 akampion http://akampioneer.com/?p=239 http://akampioneer.com/company-news/company-news-medigene-signs-commercialization-agreement-for-veregen-probiogen-is-granted-new-divisional-patent-on-duck-cell-line.html/feed 0